Viking Therapeutic (VKTX) Positive Early Data in X-ALD Adds New Future Catalyst - Raymond James
Tweet Send to a Friend
Raymond James analyst Steve Seedhouse reiterated an Outperform rating and $12.00 price target on Viking Therapeutic (NASDAQ: VKTX) after the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
